Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An update from High Tide ( (TSE:HITI) ) is now available.
On December 22, 2025, High Tide announced it will participate in the upcoming ICR Conference in Orlando, Florida, where it plans to hold two days of meetings with institutional investors and feature a fireside chat with founder and CEO Raj Grover on January 13, 2026, moderated by ROTH Capital Partners’ Bill Kirk. Management framed the invitation-only appearance as further validation of High Tide’s evolution from a pure-play cannabis company into a scaled retail platform with strong fundamentals, and positioned the event as the first in a series of major investor conferences in 2026 aimed at deepening institutional engagement and showcasing the company’s record 2025 performance, retail model, and long-term growth opportunity.
The most recent analyst rating on (TSE:HITI) stock is a Hold with a C$4.50 price target. To see the full list of analyst forecasts on High Tide stock, see the TSE:HITI Stock Forecast page.
Spark’s Take on TSE:HITI Stock
According to Spark, TipRanks’ AI Analyst, TSE:HITI is a Neutral.
High Tide’s stock score is primarily influenced by its strong financial performance, particularly in revenue growth and cash flow generation. However, the bearish technical indicators and negative valuation metrics significantly weigh down the overall score. The lack of earnings call data and corporate events further limits the assessment.
To see Spark’s full report on TSE:HITI stock, click here.
More about High Tide
High Tide Inc. is a Calgary-based, community-grown, retail-forward cannabis enterprise with fully integrated operations spanning cannabis retail, e-commerce accessories and hemp-derived CBD, and medical cannabis distribution. Its flagship banner, Canna Cabana, is the largest cannabis retail chain in Canada with 218 domestic and one international location, including a pioneering bricks-and-mortar presence in Germany, and holds about 12% of the Canadian market. Through its Remexian Pharma unit, High Tide is also a major German importer and wholesaler of medical cannabis, and the company has been repeatedly recognized among Canada’s top-growing firms and as a leading retail growth story in North America.
YTD Price Performance: -19.67%
Average Trading Volume: 109,849
Technical Sentiment Signal: Buy
Current Market Cap: C$334.5M
For an in-depth examination of HITI stock, go to TipRanks’ Overview page.